Jane Street’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding HBIO
WCM
VCM
CCM
MIM
NCNMGF
Jane Street's HBIO Position: Q1 2026 in Review
Jane Street reduced its Harvard Bioscience (HBIO) stake by 43% in Q1 2026, selling an estimated $98.9K and leaving 23,830 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #10558.
Jane Street first reported a position in HBIO in Q2 2016 and has held it in 14 quarters since. The position peaked at $357K in Q2 2019. 36 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.
- Jane Street held 23,830 shares of Harvard Bioscience worth $116K as of Q1 2026.
- Jane Street sold 17,686 Harvard Bioscience shares in Q1 2026, an estimated $98.9K.
- Harvard Bioscience made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10558 holding.
- Jane Street first reported a position in Harvard Bioscience in Q2 2016 and has held it in 14 quarters since.
- Jane Street's Harvard Bioscience position peaked at $357K in Q2 2019.
- 36 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.